Reg. No. 38/20.1.1/0133, 0127
Cefuroxime 250 mg / 500 mg
Pack: 10's
 

Reg. No. 30/20.1.1/0146
Cefadroxil 250 mg
Pack: 40's
 

Cipla-Oseltamivir is an antiviral agent used to both prevent and treat influenza infection in adults and children older than 1 year of age.
41/20.2.8/0799
Each capsule contains oseltamivir phosphate equivalent to 75 mg
oseltamivir.

Pack: 10 capsules
Oseltamivir is effective against Influenza type A and type B viruses and has proven benefits in: • Providing post-exposure prophylaxis against influenza, thereby preventing clinical influenza and reducing further transmission of the influenza virus. • Treating influenza. Oseltamivir reduces viral shedding, reduces the severity of influenza symptoms, shortens the duration of illness and is effective in reducing secondary complications of influenza when taken within 48 hours of the onset of influenza symptoms.
 

Reg. No. 36/20.1.1/0376, 0377
Ciprofloxacin Hydrochloride 250 mg / 500 mg
Pack: 10's
 

Reg. No. 34/20.1.1/0073
Doxycycline 100 mg
Pack: 42's
 

Reg. No. 29/20.1.1/0298
Doxycycline 100 mg
Pack: 100's
 

Reg. No. 31/20.2.6/0502
Mefloquine 250 mg
Pack: 6’s
 

Mosquito Repellant Patches
Pack: 24 Patches
 

Reg. No. 28/20.1.2/0239, 0240
Amoxycillin Trihydrate 250 mg / 500 mg
Pack: 500's / 100's
 

Reg. No. 37/20.1.1/0367
Roxithromycin 150 mg
Pack: 10's
 

Reg. No. 41/20.1.1/0008, 0009
Levofloxacin 500 mg / 750 mg
Pack: 5's
Cipla has launched the 500mg strength of this quinolone antibiotic as well as a 750 mg, another Cipla first in South Africa. The 750mg is a once daily dose which allows shorter duration of treatment and better compliance. The size of the fluoroquinolone market is R 252 million and with the release of Tavloxx, we anticipate gaining a healthy percentage of this.